E
Daré Bioscience, Inc. DARE
$2.04 -$0.04-1.92% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -131.11% 35.19% -8.87% 43.34% 247.35%
Total Depreciation and Amortization 2,887.66% 1,363.89% -36.00% 4.30% 60.42%
Total Amortization of Deferred Charges -127.83% 2,400.00% -- -- --
Total Other Non-Cash Items -16.19% -65.88% 249.05% -6.06% -0.19%
Change in Net Operating Assets -216.11% -17.11% 478.74% -363.16% -154.99%
Cash from Operations -141.98% 19.70% 163.90% 25.71% 295.93%
Capital Expenditure 153.79% -2,054.79% 7.33% 1,377.38% --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 153.79% -2,054.79% 7.33% 1,377.38% --
Total Debt Issued -- -- -- -6.57% --
Total Debt Repaid -680.39% 6.59% 6.59% 6.59% --
Issuance of Common Stock 159.56% 102.79% -92.94% -100.00% -59.53%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 412.50% -257.14% -100.01% -- --
Cash from Financing -137.95% 1,661.43% -102.49% -94.91% -74.48%
Foreign Exchange rate Adjustments -11.64% 133.42% -212.97% 252.67% 146.79%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -141.53% 21.58% 230.63% -1,016.75% 306.79%